GC
IMUX icon

Gratus Capital’s Immunic IMUX Stock Holding History

Gratus Capital’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$2.34M Buy
210,966
+5,685
+3% +$70.6K 0.09% 135
2024
Q1 		$2.71M Buy
205,281
+11,136
+6% +$145K 0.13% 116
2023
Q4 		$2.91M Buy
194,145
+25,499
+15% +$312K 0.17% 104
2023
Q3 		$2.48M Buy
168,646
+767
+0.5% +$14.7K 0.17% 100
2023
Q2 		$4.21M Buy
167,879
+2,338
+1% +$39.2K 0.29% 79
2023
Q1 		$2.47M Sell
165,541
-1,288
-0.8% -$23.9K 0.19% 85
2022
Q4 		$2.34M Buy
166,829
+91,510
+121% +$2.5M 0.19% 83
2022
Q3 		$2.38M Buy
+75,319
New +$3.15M 0.25% 77

Other funds holding IMUX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return